Journals / Journal of Microbiology and Infectious Diseases / 2014 / Cilt: 4 - Sayı: 3

GeneXpert vanA/vanB testi ve kültür metodu ile Vankomisin dirençli Enterokok kolonizasyonunun sürveyansı

Surveillance of Vancomycin-resistant Enterococci colonization with GeneXpert vanA/vanB test and culture method

Pages
97–101
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

J Microbiol Infect Dis 2014; 4(3): 97-101

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Early detection of vancomycin resistant enterococci (VRE) colonization in hospitalized patients plays an importantrole in controlling enterococcal infections.
📊
Key Findings & Data:In total, 2,394 rectal swab samples from 1,627 patients were collectedbetween January 2012 and 2013.
💡
Conclusion & Impact:J Microbiol Infect Dis 2014; 4(3): 97-101
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Early detection of vancomycin resistant enterococci (VRE) colonization in hospitalized patients plays an importantrole in controlling enterococcal infections. For this purpose, the detection of VRE from rectal swab specimenscan be performed with various methods.Methods: In this study, VRE colonization in the rectal swab samples of patients from intensive care units, burn unit, andinfectious diseases clinic in our hospital were evaluated. In total, 2,394 rectal swab samples from 1,627 patients were collectedbetween January 2012 and 2013. A commercial product (Enterococcosel agar) was used for cultivating, and thegrowing bacteria were identified with conventional methods and/or the VITEK 2 Compact system (BioMerieux, France).The samples of the patients transferred from another hospital and who had a history of VRE infection or carriage wereexamined with an automated real-time PCR system (Gene Xpert™ vanA/vanB, Cepheid, Sunnyvale, CA).Results: A total of 59 (3.6%) patients were positive for VRE, 25 were diagnosed with PCR, and 34 were diagnosed withculture methods. Among the samples identified by PCR, 19 were only vanA harboring VRE, five were only vanB harboringVRE, and one was both vanA and vanB harboring VRE. All of the VRE isolates were identified as E. faecium. Thenumber of patients administered with vancomycin therapy before being diagnosed with VRE was 11(18.6%).Conclusions: It is important to determine the appropriate surveillance method for the early diagnosis of VRE carriersamong patients at risk according to their patient profile, needs, and resources. J Microbiol Infect Dis 2014; 4(3): 97-101

Özet

Amaç: Hastanede yatan hastalarda vankomisin dirençli enterokok (VRE) kolonizasyonunun erken tespiti, enterokok enfeksiyonlarının kontrolünde önemli bir yer tutmaktadır. Bu amaçla rektal sürüntü örneklerinde çeşitli yöntemlerle VRE tespiti yapılabilmektedir.Yöntemler: Bu çalışmada hastanemizde Ocak 2012-2013 tarihleri arasında, yoğun bakım ünitelerinde, yanık ve enfeksiyon hastalıkları kliniklerinde yatmakta olan 1627 hastaya ait 2394 rektal sürüntü örneğinde VRE kolonizasyonu araştırıldı. Bu amaçla kültür için Enterokokosel agar kullanıldı. Üreyen bakteriler konvansiyonel yöntemler ve/veya VITEK 2 Compact (BioMerieux, Fransa) ticari sistemi kullanılarak tür düzeyinde tanımlandı. Başka bir hastaneden nakil gelen ve daha önce VRE enfeksiyonu veya taşıyıcılığı öyküsü olanlarda rektal örnekler otomatize gerçek zamanlı polimeraz zincir reaksiyonu (Realtime PCR) cihazı (Gene Xpert(TM) vanA/vanB, Cepheid, Sunnyvale, CA) ile incelendi.Bulgular: Toplam 59 hastada VRE pozitifliği (%3,6) saptandı. Bunların 25'i PCR, 34'ü ise kültür ile çalışıldı. PCR ile tanı konulanlardan 19'u vanA pozitif, 5'i vanB pozitif, biri ise vanA+vanB pozitif olarak saptandı. Vankomisin dirençli enterokok olarak belirlenen tüm suşlar E. faecium olarak tanımlandı. Hastalardan 11(%18.6)'nın VRE tanısı öncesinde tedavisinde vankomisin kullandığı saptandı.Sonuç: Riskli hastalarda VRE taşıyıcılığını erken dönemde saptayabilmek için her hastanenin kendi hasta profiline, ihtiyaçlarına ve kaynaklarına göre uygun sürveyans yöntemini belirlemesi gerektiğini düşünmekteyiz

🔖

Cite This Article

ERTEM, G. T., HATİPOĞLU, Ç. A., ALTUN, H. U., KINIKLI, S., DEMİRÖZ, A. P., YAĞCI, S., BULUT, C. (2022). GeneXpert vanA/vanB testi ve kültür metodu ile Vankomisin dirençli Enterokok kolonizasyonunun sürveyansı. Journal of Microbiology and Infectious Diseases, Cilt: 4 - Sayı: 3, 97–101. https://ajindex.com/articles/564453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-Resistant Enterococci. Clin Microbiol Rev 2000;13:686-707
  2. D’Agata EM, Horn MA, Webb GF. The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci. J Infect Dis 2002;185:766-773
  3. Sloan LM, Uhl JR, Vetter EA, et al. Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs. J Clin Microbiol 2004;42:2636-2643
  4. Clinical and Laboratory Standards Institute. M100-S23. Performance standards for antimicrobial susceptibility testing. 23th Informational Supplement M02-M07, 2013. CLSI, Wayne, PA. 5.
  5. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993;31:1280-1285
  6. Peset V, Tallón P, Sola C, et al. Epidemiological, microbiological, clinical and prognostic factors of bacteremia caused by high-level vancomycin-resistant enterococcus species. Eur J Clin Microb Infect Dis 2000;19:742-749
  7. Sakka V, Tsiodras S, Galani L, et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect 2008;14:14-21
  8. Tornieporth NG, Roberts RB, John J, et al. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996;23:767-772
  9. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin resistant enterococcus among patients with cancer. Am J Infect Control 2006;34:534-536
  10. Harris AD, Nemoy L, Johnson JA, et al. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epidemiol 2004;25:105-108
  11. Endtz HP, Braak N, Belkum A, et al. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Netherlands. J Clin Microbiol 1997;35:3026-3031
  12. Gordts B, Van Landuyt H, Ieven M, et al. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol 1995;33:2842-2846
  13. Ergani-Ozcan A, Naas T, Baysan BO, et al. Nosocomial outbre